Kalijev Klorid Jgl

Potassium Chloride, the active ingredient in Kalijev Klorid Jgl, is a potassium supplement presented as an oral formulation for oral use. It treats potassium deficiency and hypokalemia in patients who require electrolyte replacement.

GNH USA supplies Kalijev Klorid Jgl as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kalijev Klorid Jgl, a potassium supplement, is used to correct low potassium levels and support electrolyte homeostasis in various clinical settings. - Hypokalemia: Restores normal serum potassium concentrations, reducing the risk of cardiac and muscular complications. - Potassium deficiency: Replenishes depleted potassium stores, aiding proper nerve transmission and muscle contraction. - Electrolyte imbalance: Contributes to overall electrolyte balance during conditions that cause potassium loss, such as diuretic therapy or gastrointestinal losses.

Potassium chloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Abdominal discomfort - Diarrhea - Taste disturbance

Serious or Rare Side Effects: - Hyperkalemia (excessively high potassium) - Cardiac arrhythmia - Severe allergic reaction (anaphylaxis) - Muscle weakness or paralysis

Before using Kalijev Klorid Jgl, consider the following precautions to minimize risk. - Renal impairment: Monitor serum potassium closely and adjust dose as needed. - Cardiac disease: Use cautiously because rapid potassium shifts can provoke arrhythmias. - Concomitant potassium‑sparing agents: Avoid additive potassium load that may cause hyperkalemia. - Gastrointestinal disorders: Be aware of potential irritation or increased absorption. - Pregnancy and lactation: Safety has not been established; weigh benefits against potential risks. - Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Potassium chloride can interact with several medicines; awareness of key interactions helps ensure safe use.

Major Interactions (Avoid): - ACE inhibitors or ARBs: May increase serum potassium and precipitate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): Combined use can lead to dangerous potassium excess. - NSAIDs: Can reduce renal potassium excretion, raising potassium levels. - Trimethoprim: Inhibits renal potassium clearance, increasing hyperkalemia risk.

Moderate Interactions (Monitor Closely): - Digoxin: Elevated potassium can enhance digoxin toxicity. - Beta‑blockers: May mask symptoms of hypokalemia. - Certain antibiotics (e.g., aminoglycosides): Can affect renal function and potassium handling. - Insulin or glucose therapy: Shifts potassium into cells, potentially altering serum levels.